CEO & Co-founder
Steve brings over 30 years of experience building high-performing teams, products, and companies across precision medicine, drug discovery, and computational biology in the UK, Europe, and the US.
He has led the development of globally recognized genomics platforms, AI-enabled drug discovery solutions, and advanced analytics for life sciences and healthcare, resulting in multiple patented innovations. Previously, he served as Global Director of Research Informatics at Astra and contributed to the early Human Genome Project. He has collaborated with leading pharmaceutical companies on more than 30 drug discovery and development programs.
Steve is Chair of the UK BioIndustry Association’s Data, AI and Genomics Advisory Committee and a member of the Scientific Advisory Board of Our Future Health. He also serves on the Industry Advisory Groups for UK Biobank and the Health Data Research Service (HDRS), is an Expert in Residence at the University of Oxford, and an Editorial Board member for AI in the Life Sciences. He advises disease charities, national biobanks, and research institutes on precision medicine strategy.
